Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Clinical Management of Cannabis Withdrawal

This review describes the diagnosis, prevalence, course and management of cannabis withdrawal and highlights opportunities for future clinical research.
Lit review | 2021
Withdrawal, Clinical guidance

Comparison of Equivalent Doses of Fentanyl Buccal Tablets and Arteriovenous Differences in Fentanyl Pharmacokinetics

Assess whether 4x100μg fentanyl buccal tablets had the same biological effect as 1 400μg tablet
Original research | 2006
Clinical guidance, About prescribers

Hospital Buprenorphine Program for Opioid Use Disorder Is Associated With Increased Inpatient and Outpatient Addiction Treatment

This study reports the outcomes of the B-Team (Buprenorphine-Team), a hospitalist-led interprofessional program created to identify hospitalized patients with OUD, initiate buprenorphine in the inpati
Original research | 2021
Clinical guidance, Evidence base, Wrap-around services, About prescribers, Outcomes, Substitution/OAT, Transitions in care/treatment, Hospitals

Caring for hospital patients who inject drugs

Slide deck | 2019
Clinical guidance, Harm reduction, About prescribers, Illegal drugs, Hospitals

Caring for people who inject drugs when they are admitted to hospital

Commentary | 2021
Withdrawal, Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Stigma, Hospitals

National Injectable Opioid Agonist Treatment Guideline

The clinical guideline was developed to provide key clinical recommendations, as well as clinical guidance on the provision of iOAT.
Guidelines | 2019
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Illegal drugs, Stimulants, Transitions in care/treatment, Injecting drugs

BCCSU Webinars

Archived webinar | various
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Injecting drugs

BCCSU Webinars: COVID-19, Substance Use, and Safer Supply

Archived webinar | 2020
Clinical guidance, Harm reduction, Safer supply, About pharmacists, About prescribers, Housing

Fentanyl Buccal Tablet In Breakthrough Pain in Opioid-Tolerant Patients with Cancer

Report | 2006
Clinical guidance, Chronic pain

Guidance for Injectable Opiod Agonist Treatment for Opioid Use Disorder

Guidelines | 2017
Clinical guidance, Evidence base, Policy/Regulatory, About prescribers

Guideline for the Clinical Management of Opioid Use Disorder

Guidelines | 2023
Clinical guidance, Policy/Regulatory, About prescribers

Implementing social interventions in primary care

We discuss accumulated evidence (Box 1) on social interventions and provide an overview of common primary care–based interventions (Table 1), highlighting their strengths, limitations and feasibility
Lit review | 2021
Clinical guidance, Wrap-around services, Equity, About prescribers, Social services

Risk Mitigation in the Context of Dual Public Health Emergencies

BC safe suply interim guidance for safe supply/COVID-19 risk mitigation during the pandemic

Guidelines | 2022
Overdose, Clinical guidance, Harm reduction, Safer supply, About prescribers, Rural/remote, Substitution/OAT, Carries/take-home doses

Supervised Consumption Services: Operational Guidance

Guidelines | 2017
Clinical guidance, Policy/Regulatory, About prescribers, SCS/OPS

What prescribers should know about COVID-19, Substance Use and Safe Supply: New provincial clinical guidance April 2020

Slide deck | 2020
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Stimulants, Substitution/OAT, Transitions in care/treatment

Psychoactive Substance Use Policy

Alberta Health Services is committed to providing a patient-focused, quality health system that is accessible and sustainable for all Albertans.
Policy | 2020
Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Hospitals

Recommendations on Chronic Pain Practice during the COVID-19 Pandemic

This resource provides information and recommendations to chronic pain practitioners and patients during the COVID-19 pandemic.
Guidelines | 2020
Withdrawal, Clinical guidance, Harm reduction, About prescribers, Chronic pain

Affiner votre recherche

Mots clés
Format
Région